Cargando…

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Kim, Jun Pyo, Kim, Bo-Hyun, Bice, Paula J., Seo, Sang Won, Bennett, David A., Saykin, Andrew J., Nho, Kwangsik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780731/ https://www.ncbi.nlm.nih.gov/pubmed/35057845 http://dx.doi.org/10.1186/s13195-022-00960-6

Ejemplares similares

BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2021)

miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease
por: Han, Sang-Won, et al.
Publicado: (2023)

Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease
por: Park, Young Ho, et al.
Publicado: (2021)

Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology
por: Pyun, Jung‐Min, et al.
Publicado: (2022)

Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data
por: Jo, Taeho, et al.
Publicado: (2019)

Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data
por: Jo, Taeho, et al.
Publicado: (2023)

Identifying genetic variants for amyloid β in subcortical vascular cognitive impairment
por: Kim, Hang-Rai, et al.
Publicado: (2023)

Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
por: Jo, Taeho, et al.
Publicado: (2020)

Circulating lipid profiles are associated with cross-sectional and longitudinal changes of central biomarkers for Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2023)

β-amyloid and tau drive early Alzheimer’s disease decline while glucose hypometabolism drives late decline
por: Hammond, Tyler C., et al.
Publicado: (2020)

Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
por: Hirschfeld, Lauren Rose, et al.
Publicado: (2022)

Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease
por: Nho, Kwangsik, et al.
Publicado: (2017)

Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease
por: Park, Young Ho, et al.
Publicado: (2020)

Identification of functionally connected multi-omic biomarkers for Alzheimer’s disease using modularity-constrained Lasso
por: Xie, Linhui, et al.
Publicado: (2020)

Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer’s disease
por: Lee, Younghee, et al.
Publicado: (2018)

Identification of exon skipping events associated with Alzheimer’s disease in the human hippocampus
por: Han, Seonggyun, et al.
Publicado: (2019)

White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer’s disease continuum
por: Hirschfeld, Lauren Rose, et al.
Publicado: (2023)

Hippocampal transcriptome-guided genetic analysis of correlated episodic memory phenotypes in Alzheimer's disease
por: Yan, Jingwen, et al.
Publicado: (2015)

Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer’s disease
por: Kim, Dokyoon, et al.
Publicado: (2017)

From phenotype to genotype: an association study of longitudinal phenotypic markers to Alzheimer's disease relevant SNPs
por: Wang, Hua, et al.
Publicado: (2012)

Association of peripheral blood DNA methylation level with Alzheimer’s disease progression
por: Li, Qingqin S., et al.
Publicado: (2021)

Genome-Wide Association Analysis across Endophenotypes in Alzheimer’s Disease: Main Effects and Disease Stage-Specific Interactions
por: Rosewood, Thea J., et al.
Publicado: (2023)

Integrative analysis of DNA methylation and gene expression identifies genes associated with biological aging in Alzheimer's disease
por: Kim, Bo‐Hyun, et al.
Publicado: (2022)

Association of the top 20 Alzheimer's disease risk genes with [(18)F]flortaucipir PET
por: Stage, Eddie, et al.
Publicado: (2022)

Integrative analysis of eQTL and GWAS summary statistics reveals transcriptomic alteration in Alzheimer brains
por: Varathan, Pradeep, et al.
Publicado: (2022)

Systems modeling of white matter microstructural abnormalities in Alzheimer's disease
por: Horgusluoglu-Moloch, Emrin, et al.
Publicado: (2020)

Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease
por: Upadhyaya, Yurika, et al.
Publicado: (2020)

Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
por: Nho, Kwangsik, et al.
Publicado: (2021)

Rare variants in the splicing regulatory elements of EXOC3L4 are associated with brain glucose metabolism in Alzheimer’s disease
por: Miller, Jason E., et al.
Publicado: (2018)

Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology
por: Barupal, Dinesh Kumar, et al.
Publicado: (2019)

Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
por: Asanad, Samuel, et al.
Publicado: (2020)

Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model
por: Cho, Soo Min, et al.
Publicado: (2014)

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2022)

Subjective cognitive decline and rates of incident Alzheimer’s disease and non-Alzheimer’s disease dementia
por: Slot, Rosalinde E. R., et al.
Publicado: (2018)

An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification
por: Suh, Erica H., et al.
Publicado: (2023)

Cognitive decline according to amyloid uptake in patients with poststroke cognitive impairment
por: Yoon, Bora, et al.
Publicado: (2021)

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
por: Abdullah, Laila, et al.
Publicado: (2020)

CSF 14-3-3β is associated with progressive cognitive decline in Alzheimer’s disease
por: Qiang, Qiang, et al.
Publicado: (2023)

Alternative Splicing Regulation of an Alzheimer’s Risk Variant in CLU
por: Han, Seonggyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6986ghki7tlk9jqvclnksf6962